CYP2C19 Polymorphism and Clopidogrel Efficacy in Long-Term Outcomes of Large-Artery Atherosclerotic Stroke: The NCVC Genome Registry | JACC: Asia

04/11/2025 4 min
CYP2C19 Polymorphism and Clopidogrel Efficacy in Long-Term Outcomes of Large-Artery Atherosclerotic Stroke: The NCVC Genome Registry | JACC: Asia

Listen "CYP2C19 Polymorphism and Clopidogrel Efficacy in Long-Term Outcomes of Large-Artery Atherosclerotic Stroke: The NCVC Genome Registry | JACC: Asia"

Episode Synopsis

Commentary by Dr. Tong Liu.

More episodes of the podcast JACC Specialty Journals